(KALV) |
| 0 (0%) 09-16 01:58 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 31.54 |
| Resistance 1: | 27.00 |
| Pivot price: | 26.92 |
| Support 1: | 26.80 |
| Support 2: | 26.68 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -3.940 |
| Book Value | -0.380 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.098 |
| Profit Margin (%) | -118.74 |
| Operating Margin (%) | -57.37 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 11 Aug 2026
KalVista Pharmaceuticals (NASDAQ: KALV) investor reports 0% ownership in Class A stock - Stock Titan
Thu, 11 Jun 2026
KalVista (KALV) acquired by Chiesi for $27.00 per share, deal closes - Stock Titan
Sun, 31 May 2026
KalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000 - The Motley Fool
Thu, 14 May 2026
KalVista Pharmaceuticals (KALV) Earnings Date and Reports 2026 - MarketBeat
Sat, 09 May 2026
A Look At KalVista Pharmaceuticals (KALV) Valuation After A Strong Year Of Share Price Gains - Yahoo Finance
Wed, 06 May 2026
Chiesi Deal Shapes KalVista Shareholder Outlook And Valuation Potential - simplywall.st
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
